ScreenerHero
KMTSKestra Medical Technologies Ltd. Common Stock
NAS · US · Healthcare · Medical Instruments & Supplies · kestramedical.com
27.23USD-2.45%Mkt Cap: 1.64B $P/E: —

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic inte…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1

Key Statistics

Company
Market Cap1.64B $
Enterprise Value1.45B $
Revenue (TTM)95.13M $
Gross Profit48.86M $
Net Income (TTM)-131.61M $
Revenue/Share1.756 USD
Last Price27.23 USD
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees443
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.50
PEG—
EV/EBITDA-11.49
EV/Revenue15.22
P/S16.79
P/B6.13
EPS (TTM)-2.38
EPS (Forward)-2.02
52W Range
15.4281% of range30.00
52W High30.00 USD
52W Low15.42 USD
Profitability
Gross Margin51.37%
Oper. Margin-137.38%
EBITDA Margin-132.49%
Profit Margin-138.36%
ROE-50.69%
ROA-36.72%
Growth
Revenue Growth66.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-81.70M $
CapEx (TTM)35.42M $
FCF Margin-79.65%
FCF Yield-4.63%
Net Debt-149.64M $
Net Debt/EBITDA1.19
Balance Sheet
Debt/Equity0.18
Current Ratio4.41
Quick Ratio4.19
Book Value/Sh4.447 USD
Cash/Share3.352 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)30.00 USD
Upside (mean)+10.2%
Target Range28.00 USD – 32.00 USD
$28.00+10.2% to mean$32.00
# Analysts7
Ownership
Shares Out.58.60M
Float32.76M
Insiders5.30%
Institutions103.50%
Short Interest
Short Ratio8.0d
Short % Float10.58%
Short % Out.5.62%
Shares Short3.29M
Short (prev mo.)3.36M
Technical
SMA 5024.30 (+12.1%)
SMA 20023.59 (+15.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)360.51K
Avg Vol (10d)271.50K
Technical Indicators
RSI (14)63.2
MACD1.2504
MACD Signal0.9614
MACD Hist.+0.2891
BB Upper30.28 USD
BB Middle25.07 USD
BB Lower19.86 USD
BB Width41.57%
ATR (14)1.493 USD
Vol Ratio (20d)0.75x